Politan Capital Management LP’s proxy battle with health-care technology giant Masimo Corp. escalates this week as the case goes to trial in the Delaware Chancery Court. This trial is part of a broader legal conflict involving a parallel lawsuit currently pending in a California federal court. For more detail, see the original article on Bloomberg Law.
The Delaware Chancery Court, known for handling intricate corporate disputes, will now weigh in on accusations surrounding the contentious proxy battle. The case underscores the growing trend of activist investors challenging established companies through various legal means.
The week ahead will also see several other significant proceedings in the Chancery Court. On Monday, the case of Gilead Sciences v. Malik will be heard. In this case, Gilead Sciences Inc. seeks to recuperate over $4 million in legal fees from Usama Malik, the former CFO of its Immunomedics unit, amidst allegations of insider trading.
These cases reflect the complex and often high-stakes nature of litigation in the Delaware Chancery Court, a venue often at the heart of corporate governance and shareholder disputes.